Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Antizol approved in Canada for treatment of ethylene glycol poisoning

Dec. 6, 2000

Novel, orally active iron chelator APO-363: preclinical pharmacokinetics reported at AAPS

Nov. 7, 2000

NIDA grant awarded to Nabi for nicotine vaccine research

Oct. 10, 2000

Alkermes completes patient enrollment in clinical trial of new treatment for alcoholism

Oct. 3, 2000

Stimulation of brain reward areas by nicotine causes addiction

Aug. 31, 2000

Trial reveals utility of acupuncture in treating cocaine dependence

Aug. 28, 2000

Serotonin antagonist improves drinking behavior in early-onset alcoholism

Aug. 24, 2000

Orphan Medical's Antizol sNDA accepted for filing

Aug. 22, 2000

Zyban may reduce weight gain in smoking cessation

Aug. 16, 2000

Methoxsalen shown to reduce smoking by increasing the bioavailability of nicotine

July 31, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026